» Articles » PMID: 31119149

Research Progress on the Animal Models of Drug-Induced Liver Injury: Current Status and Further Perspectives

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2019 May 24
PMID 31119149
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Drug-induced liver injury (DILI) is a major concern in clinical studies as well as in postmarketing surveillance. It is necessary to establish an animal model of DILI for thorough investigation of mechanisms of DILI and searching for protective medications. This article reviews the current status and future perspective on establishment of DILI models based on different hepatotoxic drugs, as well as the underlying mechanisms of liver function damage induced by specific medicine. Therefore, information from this article can help researchers make a suitable selection of animal models for further study.

Citing Articles

In Vitro Hepatotoxicity of Routinely Used Opioids and Sedative Drugs.

Haller K, Doss S, Sauer M Curr Issues Mol Biol. 2024; 46(4):3022-3038.

PMID: 38666919 PMC: 11049542. DOI: 10.3390/cimb46040189.


Comparative analysis of gene expression between mice and humans in acetaminophen-induced liver injury by integrating bioinformatics analysis.

Zhao S, Feng Y, Zhang J, Zhang Q, Wang J, Cui S BMC Med Genomics. 2024; 17(1):80.

PMID: 38549107 PMC: 10976682. DOI: 10.1186/s12920-024-01848-0.


Eriodictyol Alleviated LPS/D-GalN-Induced Acute Liver Injury by Inhibiting Oxidative Stress and Cell Apoptosis via PI3K/AKT Signaling Pathway.

Zheng X, Wu X, Wen Q, Tang H, Zhao L, Shi F Nutrients. 2023; 15(20).

PMID: 37892424 PMC: 10609606. DOI: 10.3390/nu15204349.


Application of multiple-finding segmentation utilizing Mask R-CNN-based deep learning in a rat model of drug-induced liver injury.

Baek E, Lee J, Hwang J, Park H, Lee B, Kim Y Sci Rep. 2023; 13(1):17555.

PMID: 37845356 PMC: 10579263. DOI: 10.1038/s41598-023-44897-8.


Chemistry-Based Modeling on Phenotype-Based Drug-Induced Liver Injury Annotation: From Public to Proprietary Data.

Moein M, Heinonen M, Mesens N, Chamanza R, Amuzie C, Will Y Chem Res Toxicol. 2023; 36(8):1238-1247.

PMID: 37556769 PMC: 10445287. DOI: 10.1021/acs.chemrestox.2c00378.


References
1.
Aithal G, Rawlins M, Day C . Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions. J Hepatol. 2000; 33(6):949-52. DOI: 10.1016/s0168-8278(00)80127-0. View

2.
Odin J, Huebert R, Casciola-Rosen L, Larusso N, Rosen A . Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis. J Clin Invest. 2001; 108(2):223-32. PMC: 203018. DOI: 10.1172/JCI10716. View

3.
Su G . Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. Am J Physiol Gastrointest Liver Physiol. 2002; 283(2):G256-65. DOI: 10.1152/ajpgi.00550.2001. View

4.
Letteron P, Sutton A, Mansouri A, Fromenty B, Pessayre D . Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice. Hepatology. 2003; 38(1):133-40. DOI: 10.1053/jhep.2003.50309. View

5.
Luyendyk J, Maddox J, Cosma G, Ganey P, Cockerell G, Roth R . Ranitidine treatment during a modest inflammatory response precipitates idiosyncrasy-like liver injury in rats. J Pharmacol Exp Ther. 2003; 307(1):9-16. DOI: 10.1124/jpet.103.054288. View